Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION

  • Read more about CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION
US Patent 7,374,872
Filed on 2006-11-07

VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX

  • Read more about VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX
US Patent 7,407,658
Filed on 2006-12-15

Non-Viral Gene Delivery Complex

  • Read more about Non-Viral Gene Delivery Complex
Patent Cooperation Treaty
PCT/US2006/044525
Filed on 2006-11-20

Delayed Expression Vectors

  • Read more about Delayed Expression Vectors
Patent Cooperation Treaty
PCT/US2006/044522
Filed on 2006-11-20

Human Immunodeficiency Virus (HIV) Immunization Strategies Employing Conformationally-Stabilized, Surface-Occluded Peptides Comprising A GP41 2F5 Epitope in Association with Lipid

  • Read more about Human Immunodeficiency Virus (HIV) Immunization Strategies Employing Conformationally-Stabilized, Surface-Occluded Peptides Comprising A GP41 2F5 Epitope in Association with Lipid
US Patent 8,147,840
Filed on 2006-11-13

Compositions And Methods For Generating An Immune Response

  • Read more about Compositions And Methods For Generating An Immune Response
US Application 11/333,770
Filed on 2006-01-17

IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION.

  • Read more about IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION.
Australia
2006203490
Filed on 2006-08-11

Adenoviral Vector-based Vaccines

  • Read more about Adenoviral Vector-based Vaccines
European Patent
04779179.3
Filed on 2004-07-26

A Novel Chimeric Protein for Prevention and Treatment of HIV Infection

  • Read more about A Novel Chimeric Protein for Prevention and Treatment of HIV Infection
US Patent 8,420,099
Filed on 2006-09-27

Methods of Using Adenoviral Vector to Induced an Immune Response

  • Read more about Methods of Using Adenoviral Vector to Induced an Immune Response
South Africa
200608512
Filed on 2006-10-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 418
  • Page 419
  • Page 420
  • Page 421
  • Page 422
  • Page 423
  • Page 424
  • Page 425
  • Page 426
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health